nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—Risedronate—osteoporosis	0.562	1	CbGbCtD
Salicylate-sodium—Epistaxis—Estradiol—osteoporosis	0.000336	0.000772	CcSEcCtD
Salicylate-sodium—Anxiety—Pamidronate—osteoporosis	0.000336	0.000771	CcSEcCtD
Salicylate-sodium—Abdominal pain—Alendronate—osteoporosis	0.000335	0.000769	CcSEcCtD
Salicylate-sodium—Body temperature increased—Alendronate—osteoporosis	0.000335	0.000769	CcSEcCtD
Salicylate-sodium—Shock—Risedronate—osteoporosis	0.000334	0.000768	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Calcitriol—osteoporosis	0.00033	0.000758	CcSEcCtD
Salicylate-sodium—Abdominal pain—Raloxifene—osteoporosis	0.000329	0.000756	CcSEcCtD
Salicylate-sodium—Body temperature increased—Raloxifene—osteoporosis	0.000329	0.000756	CcSEcCtD
Salicylate-sodium—Vision blurred—Conjugated Estrogens—osteoporosis	0.000328	0.000753	CcSEcCtD
Salicylate-sodium—Urticaria—Ibandronate—osteoporosis	0.000327	0.000752	CcSEcCtD
Salicylate-sodium—Abdominal pain—Ibandronate—osteoporosis	0.000326	0.000748	CcSEcCtD
Salicylate-sodium—Body temperature increased—Ibandronate—osteoporosis	0.000326	0.000748	CcSEcCtD
Salicylate-sodium—Confusional state—Pamidronate—osteoporosis	0.000325	0.000748	CcSEcCtD
Salicylate-sodium—Syncope—Zoledronate—osteoporosis	0.000324	0.000744	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Pamidronate—osteoporosis	0.000323	0.000742	CcSEcCtD
Salicylate-sodium—Oedema—Pamidronate—osteoporosis	0.000323	0.000742	CcSEcCtD
Salicylate-sodium—Infection—Pamidronate—osteoporosis	0.000321	0.000737	CcSEcCtD
Salicylate-sodium—Urticaria—Calcitriol—osteoporosis	0.00032	0.000736	CcSEcCtD
Salicylate-sodium—Hepatitis—Estradiol—osteoporosis	0.00032	0.000735	CcSEcCtD
Salicylate-sodium—Palpitations—Zoledronate—osteoporosis	0.000319	0.000734	CcSEcCtD
Salicylate-sodium—Body temperature increased—Calcitriol—osteoporosis	0.000319	0.000733	CcSEcCtD
Salicylate-sodium—Abdominal pain—Calcitriol—osteoporosis	0.000319	0.000733	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Estradiol—osteoporosis	0.000318	0.000731	CcSEcCtD
Salicylate-sodium—Shock—Pamidronate—osteoporosis	0.000318	0.00073	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Zoledronate—osteoporosis	0.000318	0.00073	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Estropipate—osteoporosis	0.000317	0.000727	CcSEcCtD
Salicylate-sodium—Vomiting—Etidronic acid—osteoporosis	0.000316	0.000726	CcSEcCtD
Salicylate-sodium—Tachycardia—Pamidronate—osteoporosis	0.000315	0.000724	CcSEcCtD
Salicylate-sodium—Rash—Etidronic acid—osteoporosis	0.000313	0.00072	CcSEcCtD
Salicylate-sodium—Convulsion—Zoledronate—osteoporosis	0.000313	0.000719	CcSEcCtD
Salicylate-sodium—Dermatitis—Etidronic acid—osteoporosis	0.000313	0.000719	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Pamidronate—osteoporosis	0.000312	0.000717	CcSEcCtD
Salicylate-sodium—Syncope—Conjugated Estrogens—osteoporosis	0.000312	0.000717	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Alendronate—osteoporosis	0.000312	0.000716	CcSEcCtD
Salicylate-sodium—Headache—Etidronic acid—osteoporosis	0.000311	0.000715	CcSEcCtD
Salicylate-sodium—Asthenia—Estropipate—osteoporosis	0.000308	0.000708	CcSEcCtD
Salicylate-sodium—Anorexia—Pamidronate—osteoporosis	0.000308	0.000707	CcSEcCtD
Salicylate-sodium—Chest pain—Zoledronate—osteoporosis	0.000308	0.000707	CcSEcCtD
Salicylate-sodium—Palpitations—Conjugated Estrogens—osteoporosis	0.000307	0.000706	CcSEcCtD
Salicylate-sodium—Anxiety—Zoledronate—osteoporosis	0.000307	0.000704	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000306	0.000703	CcSEcCtD
Salicylate-sodium—Paraesthesia—Risedronate—osteoporosis	0.000305	0.000701	CcSEcCtD
Salicylate-sodium—Pruritus—Estropipate—osteoporosis	0.000304	0.000699	CcSEcCtD
Salicylate-sodium—Asthenia—Alendronate—osteoporosis	0.000304	0.000698	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Ibandronate—osteoporosis	0.000304	0.000698	CcSEcCtD
Salicylate-sodium—Dyspnoea—Risedronate—osteoporosis	0.000303	0.000696	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Estradiol—osteoporosis	0.000302	0.000695	CcSEcCtD
Salicylate-sodium—Hypotension—Pamidronate—osteoporosis	0.000302	0.000693	CcSEcCtD
Salicylate-sodium—Convulsion—Conjugated Estrogens—osteoporosis	0.000301	0.000693	CcSEcCtD
Salicylate-sodium—Fatigue—Ethinyl Estradiol—osteoporosis	0.0003	0.00069	CcSEcCtD
Salicylate-sodium—Pruritus—Alendronate—osteoporosis	0.000299	0.000688	CcSEcCtD
Salicylate-sodium—Dyspepsia—Risedronate—osteoporosis	0.000299	0.000687	CcSEcCtD
Salicylate-sodium—Tinnitus—Estradiol—osteoporosis	0.000298	0.000685	CcSEcCtD
Salicylate-sodium—Constipation—Ethinyl Estradiol—osteoporosis	0.000298	0.000684	CcSEcCtD
Salicylate-sodium—Confusional state—Zoledronate—osteoporosis	0.000297	0.000683	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Calcitriol—osteoporosis	0.000297	0.000683	CcSEcCtD
Salicylate-sodium—Chest pain—Conjugated Estrogens—osteoporosis	0.000296	0.000681	CcSEcCtD
Salicylate-sodium—Asthenia—Ibandronate—osteoporosis	0.000296	0.000679	CcSEcCtD
Salicylate-sodium—Anxiety—Conjugated Estrogens—osteoporosis	0.000295	0.000678	CcSEcCtD
Salicylate-sodium—Nausea—Etidronic acid—osteoporosis	0.000295	0.000678	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Zoledronate—osteoporosis	0.000295	0.000678	CcSEcCtD
Salicylate-sodium—Oedema—Zoledronate—osteoporosis	0.000295	0.000678	CcSEcCtD
Salicylate-sodium—Diarrhoea—Estropipate—osteoporosis	0.000294	0.000676	CcSEcCtD
Salicylate-sodium—Infection—Zoledronate—osteoporosis	0.000293	0.000673	CcSEcCtD
Salicylate-sodium—Fatigue—Risedronate—osteoporosis	0.000293	0.000673	CcSEcCtD
Salicylate-sodium—Pruritus—Ibandronate—osteoporosis	0.000292	0.00067	CcSEcCtD
Salicylate-sodium—Pain—Risedronate—osteoporosis	0.00029	0.000667	CcSEcCtD
Salicylate-sodium—Constipation—Risedronate—osteoporosis	0.00029	0.000667	CcSEcCtD
Salicylate-sodium—Shock—Zoledronate—osteoporosis	0.00029	0.000667	CcSEcCtD
Salicylate-sodium—Paraesthesia—Pamidronate—osteoporosis	0.00029	0.000666	CcSEcCtD
Salicylate-sodium—Diarrhoea—Alendronate—osteoporosis	0.00029	0.000665	CcSEcCtD
Salicylate-sodium—Asthenia—Calcitriol—osteoporosis	0.000289	0.000665	CcSEcCtD
Salicylate-sodium—Dyspnoea—Pamidronate—osteoporosis	0.000288	0.000661	CcSEcCtD
Salicylate-sodium—Tachycardia—Zoledronate—osteoporosis	0.000288	0.000661	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000287	0.000659	CcSEcCtD
Salicylate-sodium—Somnolence—Pamidronate—osteoporosis	0.000287	0.000659	CcSEcCtD
Salicylate-sodium—Pruritus—Calcitriol—osteoporosis	0.000285	0.000656	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Zoledronate—osteoporosis	0.000285	0.000655	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000285	0.000654	CcSEcCtD
Salicylate-sodium—Diarrhoea—Raloxifene—osteoporosis	0.000285	0.000654	CcSEcCtD
Salicylate-sodium—Dyspepsia—Pamidronate—osteoporosis	0.000284	0.000653	CcSEcCtD
Salicylate-sodium—Dizziness—Estropipate—osteoporosis	0.000284	0.000653	CcSEcCtD
Salicylate-sodium—Oedema—Conjugated Estrogens—osteoporosis	0.000284	0.000652	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000284	0.000652	CcSEcCtD
Salicylate-sodium—Infection—Conjugated Estrogens—osteoporosis	0.000282	0.000648	CcSEcCtD
Salicylate-sodium—Diarrhoea—Ibandronate—osteoporosis	0.000282	0.000648	CcSEcCtD
Salicylate-sodium—Anorexia—Zoledronate—osteoporosis	0.000281	0.000646	CcSEcCtD
Salicylate-sodium—Decreased appetite—Pamidronate—osteoporosis	0.000281	0.000645	CcSEcCtD
Salicylate-sodium—Dizziness—Alendronate—osteoporosis	0.00028	0.000643	CcSEcCtD
Salicylate-sodium—Shock—Conjugated Estrogens—osteoporosis	0.000279	0.000642	CcSEcCtD
Salicylate-sodium—Erythema—Estradiol—osteoporosis	0.000278	0.00064	CcSEcCtD
Salicylate-sodium—Fatigue—Pamidronate—osteoporosis	0.000278	0.00064	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Risedronate—osteoporosis	0.000278	0.000638	CcSEcCtD
Salicylate-sodium—Tachycardia—Conjugated Estrogens—osteoporosis	0.000277	0.000637	CcSEcCtD
Salicylate-sodium—Urticaria—Ethinyl Estradiol—osteoporosis	0.000277	0.000636	CcSEcCtD
Salicylate-sodium—Constipation—Pamidronate—osteoporosis	0.000276	0.000634	CcSEcCtD
Salicylate-sodium—Pain—Pamidronate—osteoporosis	0.000276	0.000634	CcSEcCtD
Salicylate-sodium—Diarrhoea—Calcitriol—osteoporosis	0.000276	0.000634	CcSEcCtD
Salicylate-sodium—Hypotension—Zoledronate—osteoporosis	0.000276	0.000633	CcSEcCtD
Salicylate-sodium—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000275	0.000633	CcSEcCtD
Salicylate-sodium—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000275	0.000633	CcSEcCtD
Salicylate-sodium—Dizziness—Raloxifene—osteoporosis	0.000275	0.000632	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000274	0.000631	CcSEcCtD
Salicylate-sodium—Flatulence—Estradiol—osteoporosis	0.000274	0.00063	CcSEcCtD
Salicylate-sodium—Vomiting—Estropipate—osteoporosis	0.000273	0.000628	CcSEcCtD
Salicylate-sodium—Dysgeusia—Estradiol—osteoporosis	0.000273	0.000627	CcSEcCtD
Salicylate-sodium—Dizziness—Ibandronate—osteoporosis	0.000272	0.000626	CcSEcCtD
Salicylate-sodium—Rash—Estropipate—osteoporosis	0.000271	0.000623	CcSEcCtD
Salicylate-sodium—Dermatitis—Estropipate—osteoporosis	0.000271	0.000622	CcSEcCtD
Salicylate-sodium—Anorexia—Conjugated Estrogens—osteoporosis	0.000271	0.000622	CcSEcCtD
Salicylate-sodium—Urticaria—Risedronate—osteoporosis	0.00027	0.00062	CcSEcCtD
Salicylate-sodium—Headache—Estropipate—osteoporosis	0.000269	0.000619	CcSEcCtD
Salicylate-sodium—Vomiting—Alendronate—osteoporosis	0.000269	0.000618	CcSEcCtD
Salicylate-sodium—Body temperature increased—Risedronate—osteoporosis	0.000268	0.000617	CcSEcCtD
Salicylate-sodium—Abdominal pain—Risedronate—osteoporosis	0.000268	0.000617	CcSEcCtD
Salicylate-sodium—Rash—Alendronate—osteoporosis	0.000267	0.000613	CcSEcCtD
Salicylate-sodium—Dermatitis—Alendronate—osteoporosis	0.000267	0.000613	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Pamidronate—osteoporosis	0.000266	0.000611	CcSEcCtD
Salicylate-sodium—Hypotension—Conjugated Estrogens—osteoporosis	0.000265	0.00061	CcSEcCtD
Salicylate-sodium—Headache—Alendronate—osteoporosis	0.000265	0.000609	CcSEcCtD
Salicylate-sodium—Paraesthesia—Zoledronate—osteoporosis	0.000265	0.000608	CcSEcCtD
Salicylate-sodium—Vomiting—Raloxifene—osteoporosis	0.000265	0.000608	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Pamidronate—osteoporosis	0.000264	0.000607	CcSEcCtD
Salicylate-sodium—Dyspnoea—Zoledronate—osteoporosis	0.000263	0.000604	CcSEcCtD
Salicylate-sodium—Rash—Raloxifene—osteoporosis	0.000262	0.000603	CcSEcCtD
Salicylate-sodium—Dermatitis—Raloxifene—osteoporosis	0.000262	0.000602	CcSEcCtD
Salicylate-sodium—Somnolence—Zoledronate—osteoporosis	0.000262	0.000602	CcSEcCtD
Salicylate-sodium—Vomiting—Ibandronate—osteoporosis	0.000262	0.000602	CcSEcCtD
Salicylate-sodium—Headache—Raloxifene—osteoporosis	0.000261	0.000599	CcSEcCtD
Salicylate-sodium—Rash—Ibandronate—osteoporosis	0.00026	0.000597	CcSEcCtD
Salicylate-sodium—Dermatitis—Ibandronate—osteoporosis	0.00026	0.000596	CcSEcCtD
Salicylate-sodium—Dyspepsia—Zoledronate—osteoporosis	0.00026	0.000596	CcSEcCtD
Salicylate-sodium—Headache—Ibandronate—osteoporosis	0.000258	0.000593	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000257	0.00059	CcSEcCtD
Salicylate-sodium—Vomiting—Calcitriol—osteoporosis	0.000256	0.000589	CcSEcCtD
Salicylate-sodium—Decreased appetite—Zoledronate—osteoporosis	0.000256	0.000589	CcSEcCtD
Salicylate-sodium—Nausea—Estropipate—osteoporosis	0.000255	0.000586	CcSEcCtD
Salicylate-sodium—Abdominal pain—Pamidronate—osteoporosis	0.000255	0.000586	CcSEcCtD
Salicylate-sodium—Body temperature increased—Pamidronate—osteoporosis	0.000255	0.000586	CcSEcCtD
Salicylate-sodium—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000255	0.000586	CcSEcCtD
Salicylate-sodium—Rash—Calcitriol—osteoporosis	0.000254	0.000584	CcSEcCtD
Salicylate-sodium—Fatigue—Zoledronate—osteoporosis	0.000254	0.000584	CcSEcCtD
Salicylate-sodium—Dermatitis—Calcitriol—osteoporosis	0.000254	0.000584	CcSEcCtD
Salicylate-sodium—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000253	0.000582	CcSEcCtD
Salicylate-sodium—Headache—Calcitriol—osteoporosis	0.000253	0.000581	CcSEcCtD
Salicylate-sodium—Somnolence—Conjugated Estrogens—osteoporosis	0.000252	0.00058	CcSEcCtD
Salicylate-sodium—Constipation—Zoledronate—osteoporosis	0.000252	0.000579	CcSEcCtD
Salicylate-sodium—Pain—Zoledronate—osteoporosis	0.000252	0.000579	CcSEcCtD
Salicylate-sodium—Nausea—Alendronate—osteoporosis	0.000251	0.000578	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Risedronate—osteoporosis	0.00025	0.000575	CcSEcCtD
Salicylate-sodium—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00025	0.000574	CcSEcCtD
Salicylate-sodium—Asthenia—Ethinyl Estradiol—osteoporosis	0.00025	0.000574	CcSEcCtD
Salicylate-sodium—Syncope—Estradiol—osteoporosis	0.00025	0.000574	CcSEcCtD
Salicylate-sodium—Nausea—Raloxifene—osteoporosis	0.000247	0.000568	CcSEcCtD
Salicylate-sodium—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000247	0.000567	CcSEcCtD
Salicylate-sodium—Pruritus—Ethinyl Estradiol—osteoporosis	0.000246	0.000566	CcSEcCtD
Salicylate-sodium—Palpitations—Estradiol—osteoporosis	0.000246	0.000565	CcSEcCtD
Salicylate-sodium—Fatigue—Conjugated Estrogens—osteoporosis	0.000245	0.000562	CcSEcCtD
Salicylate-sodium—Nausea—Ibandronate—osteoporosis	0.000245	0.000562	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Estradiol—osteoporosis	0.000245	0.000562	CcSEcCtD
Salicylate-sodium—Asthenia—Risedronate—osteoporosis	0.000244	0.00056	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Zoledronate—osteoporosis	0.000243	0.000558	CcSEcCtD
Salicylate-sodium—Pain—Conjugated Estrogens—osteoporosis	0.000243	0.000558	CcSEcCtD
Salicylate-sodium—Constipation—Conjugated Estrogens—osteoporosis	0.000243	0.000558	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Zoledronate—osteoporosis	0.000241	0.000554	CcSEcCtD
Salicylate-sodium—Pruritus—Risedronate—osteoporosis	0.00024	0.000552	CcSEcCtD
Salicylate-sodium—Nausea—Calcitriol—osteoporosis	0.00024	0.000551	CcSEcCtD
Salicylate-sodium—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000238	0.000548	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Pamidronate—osteoporosis	0.000238	0.000546	CcSEcCtD
Salicylate-sodium—Chest pain—Estradiol—osteoporosis	0.000237	0.000545	CcSEcCtD
Salicylate-sodium—Anxiety—Estradiol—osteoporosis	0.000236	0.000543	CcSEcCtD
Salicylate-sodium—Urticaria—Zoledronate—osteoporosis	0.000234	0.000538	CcSEcCtD
Salicylate-sodium—Body temperature increased—Zoledronate—osteoporosis	0.000233	0.000536	CcSEcCtD
Salicylate-sodium—Abdominal pain—Zoledronate—osteoporosis	0.000233	0.000536	CcSEcCtD
Salicylate-sodium—Diarrhoea—Risedronate—osteoporosis	0.000232	0.000534	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000232	0.000533	CcSEcCtD
Salicylate-sodium—Asthenia—Pamidronate—osteoporosis	0.000232	0.000532	CcSEcCtD
Salicylate-sodium—Dizziness—Ethinyl Estradiol—osteoporosis	0.00023	0.000529	CcSEcCtD
Salicylate-sodium—Confusional state—Estradiol—osteoporosis	0.000229	0.000526	CcSEcCtD
Salicylate-sodium—Pruritus—Pamidronate—osteoporosis	0.000228	0.000525	CcSEcCtD
Salicylate-sodium—Oedema—Estradiol—osteoporosis	0.000227	0.000522	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Estradiol—osteoporosis	0.000227	0.000522	CcSEcCtD
Salicylate-sodium—Infection—Estradiol—osteoporosis	0.000226	0.000519	CcSEcCtD
Salicylate-sodium—Urticaria—Conjugated Estrogens—osteoporosis	0.000226	0.000518	CcSEcCtD
Salicylate-sodium—Dizziness—Risedronate—osteoporosis	0.000225	0.000516	CcSEcCtD
Salicylate-sodium—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000224	0.000516	CcSEcCtD
Salicylate-sodium—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000224	0.000516	CcSEcCtD
Salicylate-sodium—Shock—Estradiol—osteoporosis	0.000224	0.000514	CcSEcCtD
Salicylate-sodium—Tachycardia—Estradiol—osteoporosis	0.000222	0.00051	CcSEcCtD
Salicylate-sodium—Vomiting—Ethinyl Estradiol—osteoporosis	0.000221	0.000509	CcSEcCtD
Salicylate-sodium—Diarrhoea—Pamidronate—osteoporosis	0.000221	0.000508	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Estradiol—osteoporosis	0.00022	0.000505	CcSEcCtD
Salicylate-sodium—Rash—Ethinyl Estradiol—osteoporosis	0.00022	0.000505	CcSEcCtD
Salicylate-sodium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000219	0.000504	CcSEcCtD
Salicylate-sodium—Headache—Ethinyl Estradiol—osteoporosis	0.000218	0.000501	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Zoledronate—osteoporosis	0.000217	0.000499	CcSEcCtD
Salicylate-sodium—Vomiting—Risedronate—osteoporosis	0.000216	0.000496	CcSEcCtD
Salicylate-sodium—Rash—Risedronate—osteoporosis	0.000214	0.000492	CcSEcCtD
Salicylate-sodium—Dermatitis—Risedronate—osteoporosis	0.000214	0.000492	CcSEcCtD
Salicylate-sodium—Dizziness—Pamidronate—osteoporosis	0.000213	0.000491	CcSEcCtD
Salicylate-sodium—Headache—Risedronate—osteoporosis	0.000213	0.000489	CcSEcCtD
Salicylate-sodium—Asthenia—Zoledronate—osteoporosis	0.000212	0.000486	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000209	0.000481	CcSEcCtD
Salicylate-sodium—Pruritus—Zoledronate—osteoporosis	0.000209	0.000479	CcSEcCtD
Salicylate-sodium—Nausea—Ethinyl Estradiol—osteoporosis	0.000207	0.000475	CcSEcCtD
Salicylate-sodium—Vomiting—Pamidronate—osteoporosis	0.000205	0.000472	CcSEcCtD
Salicylate-sodium—Paraesthesia—Estradiol—osteoporosis	0.000204	0.000469	CcSEcCtD
Salicylate-sodium—Asthenia—Conjugated Estrogens—osteoporosis	0.000204	0.000468	CcSEcCtD
Salicylate-sodium—Rash—Pamidronate—osteoporosis	0.000204	0.000468	CcSEcCtD
Salicylate-sodium—Dermatitis—Pamidronate—osteoporosis	0.000203	0.000467	CcSEcCtD
Salicylate-sodium—Dyspnoea—Estradiol—osteoporosis	0.000203	0.000466	CcSEcCtD
Salicylate-sodium—Headache—Pamidronate—osteoporosis	0.000202	0.000465	CcSEcCtD
Salicylate-sodium—Somnolence—Estradiol—osteoporosis	0.000202	0.000464	CcSEcCtD
Salicylate-sodium—Diarrhoea—Zoledronate—osteoporosis	0.000202	0.000464	CcSEcCtD
Salicylate-sodium—Nausea—Risedronate—osteoporosis	0.000202	0.000463	CcSEcCtD
Salicylate-sodium—Pruritus—Conjugated Estrogens—osteoporosis	0.000201	0.000462	CcSEcCtD
Salicylate-sodium—Dyspepsia—Estradiol—osteoporosis	0.0002	0.00046	CcSEcCtD
Salicylate-sodium—Decreased appetite—Estradiol—osteoporosis	0.000198	0.000454	CcSEcCtD
Salicylate-sodium—Fatigue—Estradiol—osteoporosis	0.000196	0.00045	CcSEcCtD
Salicylate-sodium—Dizziness—Zoledronate—osteoporosis	0.000195	0.000448	CcSEcCtD
Salicylate-sodium—Pain—Estradiol—osteoporosis	0.000194	0.000447	CcSEcCtD
Salicylate-sodium—Constipation—Estradiol—osteoporosis	0.000194	0.000447	CcSEcCtD
Salicylate-sodium—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000194	0.000446	CcSEcCtD
Salicylate-sodium—Nausea—Pamidronate—osteoporosis	0.000192	0.000441	CcSEcCtD
Salicylate-sodium—Dizziness—Conjugated Estrogens—osteoporosis	0.000188	0.000431	CcSEcCtD
Salicylate-sodium—Vomiting—Zoledronate—osteoporosis	0.000187	0.000431	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Estradiol—osteoporosis	0.000187	0.00043	CcSEcCtD
Salicylate-sodium—Rash—Zoledronate—osteoporosis	0.000186	0.000427	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Estradiol—osteoporosis	0.000186	0.000427	CcSEcCtD
Salicylate-sodium—Dermatitis—Zoledronate—osteoporosis	0.000186	0.000427	CcSEcCtD
Salicylate-sodium—Headache—Zoledronate—osteoporosis	0.000185	0.000424	CcSEcCtD
Salicylate-sodium—Vomiting—Conjugated Estrogens—osteoporosis	0.000181	0.000415	CcSEcCtD
Salicylate-sodium—Urticaria—Estradiol—osteoporosis	0.000181	0.000415	CcSEcCtD
Salicylate-sodium—Abdominal pain—Estradiol—osteoporosis	0.00018	0.000413	CcSEcCtD
Salicylate-sodium—Body temperature increased—Estradiol—osteoporosis	0.00018	0.000413	CcSEcCtD
Salicylate-sodium—Rash—Conjugated Estrogens—osteoporosis	0.000179	0.000411	CcSEcCtD
Salicylate-sodium—Dermatitis—Conjugated Estrogens—osteoporosis	0.000179	0.000411	CcSEcCtD
Salicylate-sodium—Headache—Conjugated Estrogens—osteoporosis	0.000178	0.000409	CcSEcCtD
Salicylate-sodium—Nausea—Zoledronate—osteoporosis	0.000175	0.000402	CcSEcCtD
Salicylate-sodium—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.000174	0.0742	CbGpPWpGaD
Salicylate-sodium—Nausea—Conjugated Estrogens—osteoporosis	0.000169	0.000388	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Estradiol—osteoporosis	0.000167	0.000385	CcSEcCtD
Salicylate-sodium—Asthenia—Estradiol—osteoporosis	0.000163	0.000375	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000161	0.069	CbGpPWpGaD
Salicylate-sodium—Pruritus—Estradiol—osteoporosis	0.000161	0.000369	CcSEcCtD
Salicylate-sodium—Diarrhoea—Estradiol—osteoporosis	0.000155	0.000357	CcSEcCtD
Salicylate-sodium—Dizziness—Estradiol—osteoporosis	0.00015	0.000345	CcSEcCtD
Salicylate-sodium—Vomiting—Estradiol—osteoporosis	0.000144	0.000332	CcSEcCtD
Salicylate-sodium—Rash—Estradiol—osteoporosis	0.000143	0.000329	CcSEcCtD
Salicylate-sodium—Dermatitis—Estradiol—osteoporosis	0.000143	0.000329	CcSEcCtD
Salicylate-sodium—Headache—Estradiol—osteoporosis	0.000142	0.000327	CcSEcCtD
Salicylate-sodium—Nausea—Estradiol—osteoporosis	0.000135	0.00031	CcSEcCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000128	0.0548	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	9.84e-05	0.0421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	9.13e-05	0.039	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	7.81e-05	0.0334	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.57e-05	0.0281	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	5.9e-05	0.0252	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	4.65e-05	0.0199	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	4.1e-05	0.0175	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	4.01e-05	0.0171	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	3.72e-05	0.0159	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP27A1—osteoporosis	3.49e-05	0.0149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	3.47e-05	0.0149	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	3.46e-05	0.0148	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.45e-05	0.0148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	3.18e-05	0.0136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	2.79e-05	0.0119	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	2.79e-05	0.0119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	2.74e-05	0.0117	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	2.67e-05	0.0114	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	2.55e-05	0.0109	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	2.35e-05	0.0101	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.33e-05	0.00997	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	2.21e-05	0.00947	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.21e-05	0.00946	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	2.12e-05	0.00908	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.07e-05	0.00887	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.07e-05	0.00885	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	2.03e-05	0.00866	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	1.89e-05	0.00806	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	1.87e-05	0.00799	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.85e-05	0.00792	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP19A1—osteoporosis	1.83e-05	0.00784	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.76e-05	0.00751	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.72e-05	0.00735	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.68e-05	0.00717	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.47e-05	0.0063	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.45e-05	0.00621	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	1.4e-05	0.00597	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LEP—osteoporosis	1.38e-05	0.00588	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.37e-05	0.00584	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.35e-05	0.00578	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.34e-05	0.00573	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.33e-05	0.00569	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.27e-05	0.00541	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.14e-05	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.11e-05	0.00474	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—osteoporosis	1.1e-05	0.00471	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.06e-05	0.00455	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PKM—osteoporosis	1.04e-05	0.00444	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FDPS—osteoporosis	1.04e-05	0.00444	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	1.01e-05	0.00434	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PGLS—osteoporosis	9.85e-06	0.00421	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPD2—osteoporosis	9.85e-06	0.00421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SOST—osteoporosis	9.85e-06	0.00421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PKM—osteoporosis	9.85e-06	0.00421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ANTXR2—osteoporosis	9.34e-06	0.00399	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PGLS—osteoporosis	9.34e-06	0.00399	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.04e-06	0.00387	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ATIC—osteoporosis	9.01e-06	0.00385	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PNP—osteoporosis	9.01e-06	0.00385	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	8.97e-06	0.00383	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.94e-06	0.00382	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	8.77e-06	0.00375	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PKM—osteoporosis	8.25e-06	0.00353	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FDPS—osteoporosis	8.25e-06	0.00353	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	8.18e-06	0.0035	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	8.05e-06	0.00344	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GSN—osteoporosis	7.94e-06	0.00339	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PGLS—osteoporosis	7.82e-06	0.00334	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPD2—osteoporosis	7.82e-06	0.00334	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.73e-06	0.00331	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—OXCT1—osteoporosis	7.66e-06	0.00327	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA2—osteoporosis	7.66e-06	0.00327	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MGLL—osteoporosis	7.46e-06	0.00319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ATIC—osteoporosis	7.15e-06	0.00306	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PNP—osteoporosis	7.15e-06	0.00306	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.04e-06	0.00301	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LRP5—osteoporosis	6.91e-06	0.00295	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MYC—osteoporosis	6.83e-06	0.00292	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	6.82e-06	0.00291	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LRP6—osteoporosis	6.61e-06	0.00282	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	6.5e-06	0.00278	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—osteoporosis	6.37e-06	0.00272	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—IDH2—osteoporosis	6.35e-06	0.00271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LTF—osteoporosis	6.35e-06	0.00271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPL24—osteoporosis	6.35e-06	0.00271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—OXCT1—osteoporosis	6.08e-06	0.0026	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA2—osteoporosis	6.08e-06	0.0026	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP27A1—osteoporosis	5.97e-06	0.00255	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MGLL—osteoporosis	5.93e-06	0.00253	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ACP5—osteoporosis	5.8e-06	0.00248	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.73e-06	0.00245	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.59e-06	0.00239	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ACP5—osteoporosis	5.5e-06	0.00235	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TPI1—osteoporosis	5.4e-06	0.00231	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—osteoporosis	5.14e-06	0.0022	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TPI1—osteoporosis	5.12e-06	0.00219	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—P4HB—osteoporosis	5.07e-06	0.00217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—IDH2—osteoporosis	5.04e-06	0.00215	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GAPDH—osteoporosis	4.98e-06	0.00213	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—RAP1A—osteoporosis	4.85e-06	0.00207	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—P4HB—osteoporosis	4.81e-06	0.00206	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP27A1—osteoporosis	4.74e-06	0.00203	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GAPDH—osteoporosis	4.72e-06	0.00202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.65e-06	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.64e-06	0.00198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ACP5—osteoporosis	4.61e-06	0.00197	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.55e-06	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NFATC1—osteoporosis	4.49e-06	0.00192	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—DKK1—osteoporosis	4.45e-06	0.0019	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.33e-06	0.00185	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—WNT1—osteoporosis	4.29e-06	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TPI1—osteoporosis	4.28e-06	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.23e-06	0.00181	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGA—osteoporosis	4.17e-06	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—P4HB—osteoporosis	4.03e-06	0.00172	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GAPDH—osteoporosis	3.95e-06	0.00169	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ENO1—osteoporosis	3.92e-06	0.00168	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PSMA2—osteoporosis	3.86e-06	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PSMA5—osteoporosis	3.86e-06	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—RAP1A—osteoporosis	3.85e-06	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ENO1—osteoporosis	3.72e-06	0.00159	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PSMA2—osteoporosis	3.66e-06	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PSMA5—osteoporosis	3.66e-06	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CALCA—osteoporosis	3.41e-06	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.36e-06	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP19A1—osteoporosis	3.13e-06	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ENO1—osteoporosis	3.11e-06	0.00133	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KL—osteoporosis	3.1e-06	0.00133	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PSMA5—osteoporosis	3.07e-06	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PSMA2—osteoporosis	3.07e-06	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADCY5—osteoporosis	2.56e-06	0.0011	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPX1—osteoporosis	2.55e-06	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP19A1—osteoporosis	2.49e-06	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ADCY5—osteoporosis	2.43e-06	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—osteoporosis	2.36e-06	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—osteoporosis	2.23e-06	0.000955	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IRS2—osteoporosis	2.12e-06	0.000908	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADCY5—osteoporosis	2.03e-06	0.000869	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPX1—osteoporosis	2.03e-06	0.000866	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—osteoporosis	1.88e-06	0.000805	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—osteoporosis	1.87e-06	0.0008	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IRS1—osteoporosis	1.85e-06	0.000793	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6R—osteoporosis	1.74e-06	0.000745	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—osteoporosis	1.5e-06	0.000639	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—osteoporosis	1.03e-06	0.000441	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—osteoporosis	1.03e-06	0.00044	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—osteoporosis	7.76e-07	0.000332	CbGpPWpGaD
